Wednesday - February 4, 2026
FDA Issues Warning Letter to Eniva USA
February 04, 2026
WASHINGTON, Feb. 4 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Eniva USA Inc. from the Human Foods Program:

* * *

Recipient: Andrew J Baechler, CEO, Eniva USA, Inc., 2700 Campus Dr., Plymouth, MN 55441-2601, United States, andyb@eniva.com

Issuing Office: Human Foods Program, United States

WARNING LETTER

CMS #706565

Dear Mr. Baechler:

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products